Form D · Biotechnology

Animal Cell Therapies, Inc.

San Diego, CA · CIK 0001470530

Offering snapshot reported Jul 17, 2019 · SEC filing

Reported sold
$5.59M
Offering amount: $10M
Investors reported
64
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 9, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.79M$5.59MMar 18, 2016: $105,000.00Mar 18, 2016Jun 5, 2017: $2,647,463.00Jun 5, 2017May 21, 2018: $4,330,484.00May 21, 2018Jul 17, 2019: $5,588,363.00Jul 17, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,330,484 → $5,588,363
  • Reported investors56 → 64

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 17, 2019Amendment$5,588,363$1,257,879vs May 21, 201864SEC filing
May 21, 2018Amendment$4,330,484$1,683,021vs Jun 5, 201756SEC filing
Jun 5, 2017Amendment$2,647,463$2,542,463vs Mar 18, 201631SEC filing
Mar 18, 2016Initial$105,000No comparison2SEC filing
Feb 9, 2015Initial$37,500No comparison1SEC filing
Jan 28, 2015Amendment$3,082,000$684,500vs Feb 4, 201454SEC filing
Feb 4, 2014Amendment$2,397,500$675,000vs Feb 5, 201338SEC filing
Feb 5, 2013Amendment$1,722,500$1,347,500vs Feb 9, 201231SEC filing
Feb 9, 2012Initial$375,000No comparison4SEC filing
Dec 7, 2010Initial$300,000No comparison3SEC filing
Aug 31, 2009Initial$1,104,000No comparison22SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-259543

Source: Form D, filed Jul 17, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Shaun Bishop Director
Stephen A. De Kanter Director
Leo Furcht Director
Derek J. Howe Director
Adam Irving Director, Executive
Roger C. Kuhn Director
Kathryn J. Petrucci Director, Executive, Promoter
Gary M. Petrucci Director
Steve Simon Director
Dean Spatz Director
Nikolai Tankovich Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11211 Sorrento Valley Road Suite A
San Diego, CA, 92121